In the version of this article initially published, there were two errors in the discussion of epigenetic marks on page 854. In sentence 4, paragraph 2 of the section "Genetic and epigenetic changes predictive of malignancy, " dimethylated and trimethylated H3K9 were said incorrectly to be "polycomb" marks. "Polycomb" has been deleted from the sentence, and the following two sentences inserted for clarification: "In ES cells these genes are held in a 'transcription ready' state by two marks, a repressive H3K27me mark and an active mark, H3K4me 64 . Changes in the balance of repressive versus active marks can alter the activity of these genes, hypothetically keeping cells in a proliferative state. " Further down in the paragraph, DNMT3L was described incorrectly as catalytic. The original text, "… related to activation of the de novo methyltransferase DNMT3L 68 " has been revised to "…and maintain expression of the de novo methyltransferase-like protein DNMT3L 68 . Expression of DNMT3L appears to be a common feature in pluripotent cells including ES, EC and embryonic germ cells. " The errors have been corrected in the HTML and PDF versions of the article.
